PLPPR3 Gene

Name phospholipid phosphatase related 3
Description The proteins in the lipid phosphate phosphatase (LPP) family, including PRG2, are integral membrane proteins that modulate bioactive lipid phosphates including phosphatidate, lysophosphatidate, and sphingosine-1-phosphate in the context of cell migration, neurite retraction, and mitogenesis (Brauer et al., 2003 [PubMed 12730698]).[supplied by OMIM, Mar 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nAlthough none of the provided abstracts mention PLPPR3 directly, they consistently describe the functions of a related protein commonly known as DLC2 (also referred to as STARD13 or START‐GAP2). In the context of cancer, studies show that DLC2 acts as a metastasis suppressor. For instance, one study demonstrated that miR‐125b promotes metastasis in breast cancer cells by targeting STARD13, leading to enhanced migratory potential, while another study using a Neu oncogene‐induced mammary tumor model revealed that loss of Stard13 increased lung metastases without affecting primary tumor growth."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOther investigations focused on the cellular mechanisms of DLC2 highlight its role as a RhoGAP that negatively regulates RhoA (and, to a lesser extent, Cdc42) activity, thereby modulating the actin cytoskeleton. Studies in fibroblasts and pancreatic β‐cells have shown that expression of DLC2 isoforms induces dramatic changes in cell morphology and suppresses stress fiber formation, effects that are attributed to decreased RhoA activity. These findings underscore the importance of DLC2 in cytoskeletal reorganization and cellular function."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition, DLC2 has been implicated in the modulation of pain signalling. Studies using DLC2‐deficient mice have revealed that the loss of DLC2 leads to enhanced inflammatory pain responses, a consequence of increased RhoA activity and downstream ROCK/p38 MAPK activation. These changes result in elevated expression of pro‐inflammatory mediators and enhanced microglial activation in the spinal dorsal horn, indicating that DLC2’s inhibitory effect on RhoA is central to controlling inflammation-induced hyperalgesia."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Feng Tang, Rui Zhang, Yunmian He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0035435"}], "href": "https://doi.org/10.1371/journal.pone.0035435"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22693547"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22693547"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Pratima Basak, Heather Leslie, Rachelle L Dillon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.22519"}], "href": "https://doi.org/10.1002/gcc.22519"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29218825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29218825"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Thomas Ho-Yin Leung, Yick-Pang Ching, Judy Wai Ping Yam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0504501102"}], "href": "https://doi.org/10.1073/pnas.0504501102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16217026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16217026"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Katsuhisa Kawai, Jun-ichi Seike, Takuya Iino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "START-GAP2/DLC2 is localized in focal adhesions via its N-terminal region."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2009.01.095"}], "href": "https://doi.org/10.1016/j.bbrc.2009.01.095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19250640"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19250640"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Heike Naumann, Thomas Rathjen, Matthew N Poy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The RhoGAP Stard13 controls insulin secretion through F-actin remodeling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Metab (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molmet.2017.12.013"}], "href": "https://doi.org/10.1016/j.molmet.2017.12.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29310936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29310936"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Fred K C Chan, Stephen S M Chung, Irene O Ng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The RhoA GTPase-activating protein DLC2 modulates RhoA activity and hyperalgesia to noxious thermal and inflammatory stimuli."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosignals (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000331240"}], "href": "https://doi.org/10.1159/000331240"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22204965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22204965"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Stanley Sau Ching Wong, Un Man Lee, Xiao-Min Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of DLC2 and RhoA/ROCK pathway in formalin induced inflammatory pain in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Lett (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neulet.2019.134379"}], "href": "https://doi.org/10.1016/j.neulet.2019.134379"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31323253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31323253"}]}]}]}
NCBI Gene ID 79948
API
Download Associations
Predicted Functions View PLPPR3's ARCHS4 Predicted Functions.
Co-expressed Genes View PLPPR3's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View PLPPR3's ARCHS4 Predicted Functions.

Functional Associations

PLPPR3 has 2,682 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 27 datasets.

Click the + buttons to view associations for PLPPR3 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of PLPPR3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of PLPPR3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CellMarker Gene-Cell Type Associations cell types associated with PLPPR3 gene from the CellMarker Gene-Cell Type Associations dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of PLPPR3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing PLPPR3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with PLPPR3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with PLPPR3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with PLPPR3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
GO Biological Process Annotations 2025 biological processes involving PLPPR3 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2025 cellular components containing PLPPR3 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by PLPPR3 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of PLPPR3 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of PLPPR3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with PLPPR3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of PLPPR3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of PLPPR3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
KEGG Pathways 2026 pathways involving PLPPR3 protein from the KEGG Pathways 2026 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of PLPPR3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
Reactome Pathways 2024 pathways involving PLPPR3 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of PLPPR3 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of PLPPR3 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of PLPPR3 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of PLPPR3 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of PLPPR3 gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of PLPPR3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of PLPPR3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with PLPPR3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.